CERVICAL SQUAMOUS CELL CARCINOMA
Clinical trials for CERVICAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CERVICAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CERVICAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Cancer's 'Extra DNA' in desperate patients
Disease control OngoingThis early-phase study tests an experimental oral drug, BBI-355, in people with advanced solid tumors (like certain breast, ovarian, lung, and other cancers) that have extra copies of cancer-driving genes. The goal is to find a safe dose and see if BBI-355, alone or with other ta…
Matched conditions: CERVICAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Boundless Bio, Inc. • Aim: Disease control
Last updated May 26, 2026 07:53 UTC
-
Could a drug combo boost survival in advanced cervical cancer?
Disease control OngoingThis study tests whether adding the drug triapine to standard radiation and chemotherapy (cisplatin) helps women with advanced cervical or vaginal cancer live longer. About 450 women with newly diagnosed, bulky or advanced cancer will be randomly assigned to receive either standa…
Matched conditions: CERVICAL SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New combo therapy targets Hard-to-Treat cancers
Disease control OngoingThis early-stage trial tests a combination of two drugs, naptumomab estafenatox and durvalumab, in 120 adults with advanced or metastatic solid tumors that have not responded to standard treatments. The main goal is to find safe doses and check for side effects, while also measur…
Matched conditions: CERVICAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: NeoTX Therapeutics Ltd. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC